We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The Office of New Drugs will gain an Office of Therapeutic Biologics and Biosimilars to bolster reviews of biosimilars and interchangeable products as well as biologics. Read More
The agency said applicants should determine the biocompatibility of all parts in the biliary stent and the delivery system that touch the patient. Read More